Neutrophil Receptor Mrgpra2 Identified as Key Driver of Itch and Skin Changes in Atopic Dermatitis Mouse Model
Researchers have identified the neutrophil receptor Mrgpra2 as a significant contributor to chronic itch and skin pathology in a mouse model of atopic dermatitis. Genetic deletion of Mrgpra2 in mice substantially reduced scratching behavior, skin barrier dysfunction, epidermal thickening, and expression of the inflammatory cytokine TSLP. The finding opens a potential new therapeutic target for the millions of people suffering from moderate-to-severe eczema, for whom chronic itch remains difficult to manage.
A new preprint study posted to bioRxiv reports that the Mas-related G protein-coupled receptor Mrgpra2, expressed on neutrophils, plays a meaningful role in the development of atopic dermatitis (AD) symptoms in mice. Atopic dermatitis affects an estimated 30 million Americans, with over 6 million experiencing moderate or severe disease, and chronic pruritus remains one of its most challenging symptoms to treat. The researchers used a genetic knockout approach, deleting Mrgpra2 in mice, and observed significant reductions in scratching behavior, transepidermal water loss, epidermal hyperplasia, and thymic stromal lymphopoietin (TSLP) expression — all hallmarks of AD pathology. This work builds on a growing body of research implicating Mrgpr family receptors in itch signaling, which has already contributed to the development of novel anti-pruritic therapeutics. By specifically implicating a neutrophil-expressed receptor, the study highlights a potentially underappreciated immune cell type in the itch cascade of AD. The findings suggest that targeting Mrgpra2 or its downstream pathways could represent a new avenue for therapeutic intervention, though translation from mouse models to humans will require further investigation.
What's missing
As a preprint, this study has not yet undergone peer review. The study is conducted entirely in mice, and the human ortholog of Mrgpra2 has not been clearly established, raising questions about direct translational relevance. The specific mechanism by which neutrophil-expressed Mrgpra2 communicates with sensory neurons to produce itch is not described. The study does not address whether Mrgpra2 expression or activity is altered in human AD patients.
What different sources said
- bioRxivCenter
The role of the neutrophil receptor Mrgpra2 in the formation of itch in atopic dermatitis
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.